o-(4-ethoxybutyl)berbamine has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, XH; Fan, DM; Liu, R; Qi, J; Xiong, DS; Yang, CZ; Yang, M; Zhou, Y; Zhu, HF | 1 |
Cheng, YH; Liu, JW; Pan, B; Qi, J; Qi, SL; Xiong, DS; Yang, CZ; Zhu, HF | 1 |
2 other study(ies) available for o-(4-ethoxybutyl)berbamine and Breast Cancer
Article | Year |
---|---|
[Effect of calmodulin antagonist O-4-ethoxyl- butyl-berbamine on the proliferation of human breast cancer cell line MCF-7 and its relevant mechanism].
Topics: Benzylisoquinolines; Breast Neoplasms; Calmodulin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans | 2009 |
[Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Breast Neoplasms; Calmodulin; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans | 2006 |